Keith Katkin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Katkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Katkin. Keith Katkin is President and CEO in AVANIR PHARMACEUTICALS, INC. ($AVNR).
Latest Insider Trading Transactions of Keith Katkin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | M | 0.53 | 195,300 | 103,509 | 251,100 | |
| Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | A | 4.18 | 400,000 | 1,672,000 | 400,000 | |
| Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 4.08 | 195,300 | 797,254 | 208,352 | 403.7 K to 208.4 K (-48.38 %) |
| Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | M | 0.53 | 195,300 | 103,509 | 403,652 | 208.4 K to 403.7 K (+93.74 %) |
| Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Grant | A | 0.00 | 62,500 | 0 | 208,352 | 145.9 K to 208.4 K (+42.85 %) |
| Nov 02 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 5.70 | 20,000 | 114,000 | 145,852 | 165.9 K to 145.9 K (-12.06 %) |
| Sep 15 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 2.70 | 1,321 | 3,567 | 165,852 | 167.2 K to 165.9 K (-0.79 %) |
| Sep 02 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.83 | 62,874 | 177,864 | 167,173 | 230 K to 167.2 K (-27.33 %) |
| Sep 02 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.86 | 40,000 | 114,512 | 230,047 | 270 K to 230 K (-14.81 %) |
| Jun 15 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 2.71 | 1,320 | 3,577 | 270,047 | 271.4 K to 270 K (-0.49 %) |
| May 04 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 3.06 | 65,906 | 201,376 | 271,367 | 337.3 K to 271.4 K (-19.54 %) |
| May 04 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 3.31 | 40,000 | 132,372 | 337,273 | 377.3 K to 337.3 K (-10.60 %) |
| Apr 09 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 3.01 | 10,000 | 30,100 | 377,273 | 387.3 K to 377.3 K (-2.58 %) |
| Mar 31 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 2.60 | 30,000 | 78,000 | 387,273 | 417.3 K to 387.3 K (-7.19 %) |
| Mar 16 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 2.13 | 1,317 | 2,805 | 417,273 | 418.6 K to 417.3 K (-0.31 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.96 | 6,000 | 11,766 | 418,001 | 424 K to 418 K (-1.42 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.96 | 2,000 | 3,921 | 424,001 | 426 K to 424 K (-0.47 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.94 | 2,000 | 3,880 | 426,001 | 428 K to 426 K (-0.47 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.94 | 900 | 1,746 | 428,001 | 428.9 K to 428 K (-0.21 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.93 | 100 | 193 | 428,901 | 429 K to 428.9 K (-0.02 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.93 | 3,100 | 5,985 | 429,001 | 432.1 K to 429 K (-0.72 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.93 | 925 | 1,785 | 432,101 | 433 K to 432.1 K (-0.21 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.91 | 1,500 | 2,865 | 433,026 | 434.5 K to 433 K (-0.35 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.90 | 15,000 | 28,508 | 434,526 | 449.5 K to 434.5 K (-3.34 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.90 | 2,600 | 4,940 | 449,526 | 452.1 K to 449.5 K (-0.58 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.88 | 900 | 1,692 | 452,126 | 453 K to 452.1 K (-0.20 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.97 | 4,872 | 9,598 | 453,026 | 457.9 K to 453 K (-1.06 %) |
| Jan 05 2010 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.97 | 47,274 | 93,130 | 457,898 | 505.2 K to 457.9 K (-9.36 %) |
| Dec 16 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.84 | 2,000 | 3,680 | 505,172 | 507.2 K to 505.2 K (-0.39 %) |
| Dec 16 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.83 | 18,408 | 33,687 | 507,172 | 525.6 K to 507.2 K (-3.50 %) |
| Dec 16 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.82 | 2,000 | 3,640 | 525,580 | 527.6 K to 525.6 K (-0.38 %) |
| Dec 16 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Sell | S | 1.81 | 14,927 | 27,018 | 527,580 | 542.5 K to 527.6 K (-2.75 %) |
| Dec 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.82 | 1,320 | 2,402 | 542,507 | 543.8 K to 542.5 K (-0.24 %) |
| Nov 30 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | A | 1.74 | 417,600 | 726,624 | 417,600 | |
| Sep 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 2.21 | 1,287 | 2,844 | 543,827 | 545.1 K to 543.8 K (-0.24 %) |
| Jul 17 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 2.13 | 4,749 | 10,115 | 545,114 | 549.9 K to 545.1 K (-0.86 %) |
| Jul 17 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 2.13 | 42,292 | 90,082 | 549,863 | 592.2 K to 549.9 K (-7.14 %) |
| Jun 15 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.31 | 1,287 | 1,686 | 592,155 | 593.4 K to 592.2 K (-0.22 %) |
| Feb 25 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | P | 0.44 | 14,100 | 6,204 | 593,442 | 579.3 K to 593.4 K (+2.43 %) |
| Feb 25 2009 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Buy | P | 0.43 | 900 | 387 | 579,342 | 578.4 K to 579.3 K (+0.16 %) |
| Dec 18 2008 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Option Exercise | A | 0.53 | 446,400 | 236,592 | 446,400 | |
| Jun 16 2008 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.11 | 1,287 | 1,429 | 578,442 | 579.7 K to 578.4 K (-0.22 %) |
| Mar 17 2008 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.10 | 1,539 | 1,693 | 579,729 | 581.3 K to 579.7 K (-0.26 %) |
| Dec 17 2007 | AVNR | AVANIR PHARMACEUTI ... | Katkin Keith | President and CEO | Payment of Exercise | F | 1.66 | 5,148 | 8,546 | 581,268 | 586.4 K to 581.3 K (-0.88 %) |
Page: 1